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Summary
Background: Oral lichen planus (OLP) is a precancerous lesion which might progress into oral squamous cell cancer 
(OSCC) in 0-1.2 % of the aff ected patients. Albeit there are many published studies upon this topic, there are no universally 
accepted clinical and histopathological criteria which would suggest which patients will develop OSCC. Therefore, the aim 
of this study was to compare epithelial and sub-epithelial FHIT and Bcl-2 expression between patients with OLP, OSCC and 
healthy oral mucosa.Materials and Methods: Fifty patients with OLP, 20 with OSCC who had histologically confi rmed 
 diagnoses and 20 healthy controls were included in this study. Immuno-histochemical analysis was performed on primary 
monoclonal antibodies Bcl-2 (Dako, Finland) and FHIT (Zymed Laboratories Inc., USA) were used. Statistical analysis 
 included Kolmogorov-Smirnoff  test, χ2 test and Spearman’s correlation. All p values lower than p<0.05 were considered as 
signifi cant. Results: Expression of FHIT in the OLP and OSCC epithelium is signifi cantly decreased when compared to the 
healthy oral mucosa. However, no signifi cant diff erences between FHIT expression between OLP and OSCC could be found. 
OLP and OSCC patients have signifi cantly increased expression values of Bcl-2 in the epithelium when compared to the 
epithelium of healthy participants. Furthermore, Bcl-2 expression is signifi cantly increased in patients with OLP when 
 compared to the patients with OSCC. Sub-epithelial infi ltrate in OLP and OSCC reveals signifi cantly higher Bcl-2 expression 
when compared to the healthy controls. However, Bcl-2 expression in the infl ammatory infi ltrate is signifi cantly higher in 
OSCC patients when compared to the OLP patients. Conclusion: Loss of FHIT expression in the epithelium is not suffi  cient 
for malignant transformation in OLP patients. It seems that other molecular changes are needed for OLP progression into 
OSCC. Bcl-2 expression in the infl ammatory infi ltrate is signifi cantly higher in OSCC patients when compared to the OLP 
patients and healthy controls, however bcl-2 expression in the epithelium does not correlate with precancerous (OLP) and 
OSCC lesions.
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ZNAČAJ FHIT I Bcl-2 U BOLESNIKA S ORALNIM LIHEN PLANUSOM U USPOREDBI 
S ZDRAVOM ORALNOM SLUZNICOM I ORALNIM KARCINOMOM PLOČASTIH STANICASAŽETAK
Sažetak
Uvod: Oralni lihen planus (OLP) je prekancerozna lezija koji u 0-1,2 % oboljelih može progredirati u oralni karcinom 
pločastih stanica (OKPS). Premda su objavljeni brojni radovi na ovu temu, ne postoje opće prihvaćeni klinički i patohisto-
loški kriteriji koji bi upućivali na to u kojih će se bolesnika razviti OKPS. Dakle, cilj je ovog istraživanja bio usporediti 
Lib Oncol. 2017;45(1):9–14
10
 ekspresiju FHIT i Bcl-2 u epitelu i subepitelu pacijenata s OLP, OKPS te osoba sa zdravom oralnom sluznicom. Materijal i 
metode: U istraživanje je bilo uključeno pedeset pacijenata s histološki potvrđenom dijagnozom OLP, 20 pacijenata s histo-
loški potvrđenom dijagnozom OKPS te 20 zdravih pacijenata kao kontrolna skupina. Korištene su imunohistokemijske 
analize na primarnim monoklonim protutijelima Bcl (Dako, Finska) i FHIT (Zymed Laboratories Inc., SAD). U statističkoj 
analizi korišteni su Kolmogorov-Smirnovljev test, hi kvadrat test i Spearmanov koefi cijent korelacije. P vrijednosti manje od 
0.05 su smatrane značajnima. Rezultati: Ekspresija FHIT u epitelu zahvaćenom s OLP i OKPS je značajno smanjena u uspo-
redbi sa zdravom oralnom sluznicom. Međutim, nije nađena značajna razlika u FHIT ekspresiji kod OLP i OKPS. Pacijenti 
oboljeli od OLP i OKPS imaju značajno pojačanu ekspresiju Bcl-2 u usporedbi s zdravim sudionicima. Nadalje, Bcl-2 ekspre-
sija je značajno veća u pacijenata s OLP, nego u pacijenata s OKPS. Subepitelni infi ltrat u pacijenata s OLP i OKPS pokazuje 
značajno povećanje Bcl-2 ekspresije u odnosu na zdrave osobe iz kontrolne skupine. Međutim, Bcl-2 ekspresija u upalnom 
infi ltratu je značajno viša u OKPS pacijenata nego li u OLP pacijenata. Zaključak: Gubitak FHIT ekspresije u epitelu sam po 
sebi nije dovoljan za zloćudnu transformaciju kod pacijenata koji boluju od OLP. Čini se da su za progresiju OLP u OKPS 
potrebne i druge molekularne promjene. Ekspresija Bcl-2 u upalnom infi ltrate je znakovito visa u bolesnika s OPKS u 
 odnosu na bolesnicke s OLP i zdrave kontrole, ipak, ekspresija bcl-2 u epitelu ne korelira s prekanceroznim (OLP) odnosno 
lezijama OPKS.
KLJUČNE RIJEČI: oralni lihen planus, FHIT, Bcl-2, oralni planocelularni karcinom
been described (5, 6, 7). Numerous researchers 
confi rm that FHIT gene is signifi cantly inactivated 
in the precancerous lesions as well as in cancer. 
Loss of FHIT expression especially in OSCC sug-
gest poor prognosis of these patients. It seems that 
loss of FHIT expression might be potentially use-
ful marker for early carcinogenesis (7).ne kuzim 
komentar recenzenta ovdje je jasno navedeno sto 
su bcl-2 I FHIT
We assumed that the diff erence in the FHIT 
and Bcl-2 expression in patients with OLP might 
diff erentiate subgroup of OLP patients which are 
prone to the malignant transformation into OSCC. 
Therefore, those patients might have benefi t from 
more intensive follow-up.The aim of this study 
was:
1.  To compare FHIT expression in the oral 
epithelium between patients with OLP, 
OSCC and healthy oral mucosa.
2.  To compare Bcl-2 expression in the oral 
epithelium between patients with OLP, 
OSCC and healthy oral mucosa.
3.  To compare Bcl-2 expression in the sub-
epithelial infl ammatory infi ltrate between 
patients with OLP, OSCC and healthy oral 
mucosa.
MATERIALS AND METHODS
This study which was a retrospective one 
based on the histopathological data and was ap-
proved by Ethical Committ ee of the Sestre mi-
INTRODUCTION
Oral lichen planus is a chronic autoimmune 
disease of unknown aetiology which may aff ect 
skin, oral, vaginal, and anal and oesophageal mu-
cosa (1). According to the WHO it is precancerous 
oral lesion with diff erent malignant potential 
ranging from 0-1.2%. It seems that OLP lesions 
have higher proliferative level of the basal cells, 
therefore also the ability to accumulate irreparable 
DNA damage which adds to the malignant trans-
formation. Key role in the accumulation of DNA 
damage has Bcl-2 family as they regulate apopto-
sis. Damage of Bcl-2 genes lead to the develop-
ment of various cancers such as melanoma, breast 
cancer, prostate cancer, chronic leukaemia and 
lung cancer (2). Studies have shown that Bcl-2 ex-
pression in oral dysplastic changes is more fre-
quent when compared to the hyperplastic oral 
changes; therefore increased Bcl-2 expression 
might correlate with the dysplasia or invasion of 
the tissues. Recent studies reported that cell pro-
liferation in OLP is higher when compared to the 
healthy oral mucosa, but lower when compared to 
the epithelial dysplasia and OSCC (3). Increased 
Bcl-2 expression is not only essential for oral carci-
nogenesis; it also has infl uence on the disease pro-
gression as it increases the life of neoplastic cells 
and fosters genetic mutations (4). Gene FHIT 
(Fragile Histidine Triad) is a most fragile place in 
the human genome. Much depletion in the pre-
cancerous lesions and malignant tumours which 
manifested as lost or reduced expression have 
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losrdnice University Hospital Center. Fifty sam-
ples of the OLP patients mainly situated on buccal 
mucosa, 20 samples of patients with OSCC major-
ity developed on basis in oral cavity and 20 healthy 
controls without oral diseases some localized on 
buccal some on base of oral cavity were included 
in the study. Material was fi xed in the 10% buff -
ered formalin which is later put in the paraffi  n 
blocks and cut (5μm), deparaffi  nised and stained 
with hemalaun eosin. For immune-histochemical 
analysis sections of the aforementioned paraffi  n 
blocks were used and primary monoclonal anti-
bodies Bcl-2 (code number No. MO887, Dako, Fin-
land) and FHIT (code number 71-9000, Zymed 
Laboratories Inc., USA) were used. Immuno-histo-
chemical reaction to Bcl-2 was semi-quantitatively 
determined in four categories; based on the num-
ber of positive citoplasmatic or membrene cell ex-
pression. Thus grade 1 expression included those 
samples with less than 10% expression, grade 2 
included samples showing 10-30% expression, 
grade 3 included samples exhibiting 31-60% and 
grade 4 included samples showing greater than 
61% positive cells according to Ravi et al. (8). Im-
muno-histochemical reaction to FHIT was semi-
quantitatively determined in two categories; as 
‘negative’ or ‘low expression’ (no staining or im-
munoreactivity staining present in <10% of tumor 
cells) or ‘positive’ (immunoreacitvity ≥10% of tu-
mor cells) as decribed by Kujani et al. (9). Stats Di-
rect version 3.0.86. was used for data analysis. Sta-
tistical analysis included Kolmogorov-Smirnoff 
test in order to check data distribution, and mostly 
nonparametric tests were used except for the age 
of the participants. χ2 test was used in order to 
distinguish categorical values between tested 
groups (OLP, OSCC and healthy controls). Spear-
man’s correlation was used in order to obtain pos-
sible signifi cant correlation between clinical pa-
rameters of the disease and age, i.e. certain param-
eters in the infl ammatory infi ltrate. All p values 
lower than p<0.05 were considered as signifi cant.
RESULTS
Table 1. reveals diff erences in the FHIT ex-
pression within epithelium between patients with 
OLP, OSCC and healthy oral mucosa. FHIT ex-
pression >10% was signifi cantly more present in 
the epithelium of healthy oral mucosa when com-
pared to the OLP and OSCC. No diff erences be-
tween OLP and OSCC regarding FHIT expression 
within epithelium were found.
Table 2 shows diff erences in the FHIT expres-
sion within infl ammatory infi ltrate between pa-
Table 1.
DIFFERENCES IN THE FHIT EXPRESSION WITHIN EPITHELIUM BETWEEN PATIENTS WITH OLP, 











and healthy oral 
mucosa
OLP OSCC Healthy oral mucosa
N % N % N %
FHIT
epithelium








P=0.004>10% 20 40% 5 25% 14 70%
Table 2.
DIFFERENCES IN THE FHIT EXPRESSION WITHIN INFLAMMATORY INFILTRATE BETWEEN PATIENTS WITH OLP, 











and healthy oral 
mucosa













P<0.001>10% 33 66% 11 55% 0 0%
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tients with OLP, OSCC and healthy oral mucosa. 
FHIT expression >10% was signifi cantly more pre-
sent in the infl ammatory infi ltrate of the healthy 
oral mucosa when compared to OLP and OSCC. 
Diff erence in FHIT expression of the infl ammato-
ry infi ltrate between OLP and OSCC was not sig-
nifi cant.
When compared to the healthy oral mucosa, 
bcl-2 expression is signifi cantly higher in the epi-
thelium of the OLP and OSCC patients. Signifi -
cantly higher bcl-2 expression is found in patients 
with OLP when compared to the ones with OSCC.
When compared to the healthy oral mucosa, 
bcl-2 expression is signifi cantly higher in the in-
fl ammatory infi ltrate of the OLP and OSCC pa-
tients. Signifi cantly higher bcl-2 expression is 
found in the infl ammatory infi ltrate of patients 
with OSCC when compared to the ones with OLP.
DISCUSSION
Our results are in concordance with the re-
sults of Fitz patrick et al. (10) and Reibel (11) who 
reported that malignant transformation of OLP 
was 1.09%. Latest research have shown that ele-
vated Bcl-2 expression in the epithelium and in-
fl ammatory infi ltrate might have role in the malig-
nant transformation as well as in the progression 
of the disease as reported by Sudha et al. (12). Pi-
gatt i et al. (13) reported that staining for Bcl-2 in 
infl ammatory infi ltrate in OLP was positive in 
92.9% of sections. Shailaja et al. (14) stated that sig-
nifi cant expression of Bcl-2 marker in patients 
with OLP and oral epithelial dysplasia was seen. 
In this study signifi cant Bcl-2 expression in the 
OLP epithelium when compared to the OSCC tis-
sues might depict OLP patients which are prone 
to OSCC. Most of the OLP patients were grouped 
within Bcl-2 expression from 10-30%, therefore 
those patients might have benefi t from more in-
tensive follow-up. As this was a retrospective 
study this fact could not be confi rmed as prospec-
tive studies are needed. It seems that other mecha-
nisms besides epithelial changes are needed for 
OLP progression into OSCC. Contrary to our re-
sults, Nafarzadeh et al. (15) Bcl-2 was negative for 
all OLP and normal mucosa samples, and weak 
positivity was observed in OSCC samples. Leyva-
Huerta et al. (16) reported that Bcl-2 was negative 
for all OLP and OSCC cases, and mild positivity 
was observed in the normal tissue. Furthermore, 
Table 3.












and healthy oral 
mucosa
OLP OSCC Healthy oral mucosa
N N %
Bcl-2 










10-30% 30 60% 4 20% 0 0%
31-60% 13 26% 2 10% 0 0%
>60% 3 6% 3 15% 0 0%
Table 4.
DIFFERENCE IN BCL-2 EXPRESSION IN THE INFLAMMATORY INFILTRATE BETWEEN PATIENTS WITH OLP, 











and healthy oral 
mucosa
OLP OSCC Healthy oral mucosa
N N %
Bcl-2 










10-30% 27 54% 5 25% 3 15%
31-60% 15 30% 10 50% 0 0%
>60% 1 2% 3 15% 0 0%
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Hadzi-Mihailovic et al. (17) concluded that Bcl-2 
may not serve as a prognostic biomarker in oral 
cancer development from OLP, but it could help 
in selecting patients with higher need of follow up 
to prevent malignancy. de Sousa et al. (18) found 
no signifi cant diff erences between the expression 
of bcl-2 in oral lichen planus and oral squamous 
cell carcinoma.
Signifi cant diff erence in FHIT expression be-
tween patients with OLP and healthy oral mucosa 
as well as no diff erence in comparison to the OSCC 
might lead to the conclusion that OLP lesions only 
in some cases behave as precancerous lesions. van 
Heerden et al. (19) reported that FHIT tumour 
suppressor protein is abundantly expressed in 
normal epithelial cells of human organs and that 
this expression is lost or reduced in the majority of 
cancers arising in these epithelial tissues which 
was seen in about 60% of OSCC who have lost 
FHIT expression. However, signifi cant diff erence 
in FHIT expression in OLP patients when com-
pared to the healthy oral mucosa suggests that 
certain changes have occurred in the OLP epithe-
lium, albeit these changes are not suffi  cient in or-
der to diff erentiate OLP patients who are prone to 
the OSCC development. Yin et al. (20) reported 
that the rate of the negative or low FHIT expres-
sion in OSCC was 17% which was signifi cantly 
lower when compared to the healthy oral mucosa 
and oral precancerous lesions. In the other study, 
Yin et al. (21) stated that the positivity rate of FHIT 
in healthy oral mucosa was 100% and medium 
and high FHIT expression levels were detected in 
oral precancerous lesions but without signifi cance 
when compared to the healthy oral mucosa. The 
rate of negative or low FHIT expression in the oral 
squamous cell carcinoma was 17% which was sig-
nifi cantly diff erent from the normal oral mucosa 
and oral precancerous lesions.
CONCLUSION
1.  Expression of FHIT in the epithelium of 
OLP and OSCC is signifi cantly decreased 
when compared to the epithelium of the 
healthy oral mucosa. However, no signifi -
cant diff erences between FHIT expression 
between OLP and OSCC could be found.
2.  OLP and OSCC patients have signifi cantly 
increased expression values of Bcl-2 in the 
epithelium when compared to the epithe-
lium of healthy participants. Furthermore, 
Bcl-2 expression is signifi cantly increased 
in patients with OLP when compared to 
the patients with OSCC.
3.  Sub-epithelial infi ltrate in OLP and OSCC 
patients reveals signifi cantly higher Bcl-2 
expression when compared to the healthy 
controls. However, Bcl-2 expression in the 
infl ammatory infi ltrate is signifi cantly 
higher in OSCC patients when compared 
to the OLP patients.
4.  Extremely strong and signifi cant positive 
Bcl-2 expression in the epithelium and 
sub-epithelial infl ammatory infi ltrate in 
OLP patients could be noticed.
5.  Loss of FHIT expression in the epithelium 
is necessary, however not suffi  cient for 
malignant transformation in OLP patients. 
It seems that other molecular changes 
are needed for OLP lesions to develop in 
OSCC.
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